Evidence map›Paper›PMID 30508043›Full record

ArticleInvestigative ophthalmology & visual science2018

RF/6A Chorioretinal Cells Do Not Display Key Endothelial Phenotypes.

Ryan D Makin, Ivana Apicella, Yosuke Nagasaka, Hiroki Kaneko, Stephen D Turner, Nagaraj Kerur, Jayakrishna Ambati, Bradley D Gelfand

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Cell Line Authentication in Vision Research and Beyond: A Tale Retold.Investigative ophthalmology & visual science · 2020
    Article
  5. CXCR7 Inhibits Fibrosis via Wnt/BioMed research international · 2020
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryan D MakinCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, United States.
Ivana ApicellaCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, United States.
Yosuke NagasakaDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hiroki KanekoDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Stephen D TurnerDepartment of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States.
Nagaraj KerurCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, United States.
Jayakrishna AmbatiCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, United States.
Bradley D GelfandCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, United States.

Funding

Form and function of our Janus faced genomeDP1GM114862 · NIGMS · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA · 2014 to 2018
$4.0M
Functional studies of DICER1 and Alu RNA in geographic atrophyR01EY022238 · NEI · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA · 2012 to 2016
$3.3M
Inflammasome Activation in Geographic AtrophyR01EY024068 · NEI · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA · 2014 to 2017
$2.6M
Antigen-independent suppression of ocular angiogenesis via the Fc receptorR01EY028027 · NEI · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA, GELFAND, BRADLEY DAVID · 2018 to 2022
$2.2M
Non-canonical NLRP3 Inflammasome Activation in Geographic AtrophyR00EY024336 · NEI · UNIVERSITY OF VIRGINIA · PI KERUR, NAGARAJ · 2016 to 2018
$747k
Non-canonical NLRP3 Inflammasome Activation in Geographic AtrophyK99EY024336 · NEI · UNIVERSITY OF KENTUCKY · PI KERUR, NAGARAJ · 2014 to 2015
$175k
NEI NIH HHS K99 EY024336NEI NIH HHS R00 EY024336NEI NIH HHS R01 EY022238NEI NIH HHS R01 EY024068NEI NIH HHS R01 EY028027NIGMS NIH HHS DP1 GM114862
6 · The paper itself

Abstract

Purpose: The misuse of inauthentic cell lines is widely recognized as a major threat to the integrity of biomedical science. Whereas the majority of efforts to address this have focused on DNA profiling, we sought to anatomically, transcriptionally, and functionally authenticate the RF/6A chorioretinal cell line, which is widely used as an endothelial cell line to model retinal and choroidal angiogenesis. Methods: Multiple vials of RF/6A cells obtained from different commercial distributors were studied to validate their genetic, transcriptomic, anatomic, and functional fidelity to bona fide endothelial cells. Results: Transcriptomic profiles of RF/6A cells obtained either de novo or from a public data repository did not correspond to endothelial gene expression signatures. Expression of established endothelial markers were very low or undetectable in RF/6A compared to primary human endothelial cells. Importantly, RF/6A cells also did not display functional characteristics of endothelial cells such as uptake of acetylated LDL, expression of E-selectin in response to TNF-α exposure, alignment in the direction of shear stress, and AKT and ERK1/2 phosphorylation following VEGFA stimulation. Conclusions: Multiple independent sources of RF/6A do not exhibit key endothelial cell phenotypes. Therefore, these cells appear unsuitable as surrogates for choroidal or retinal endothelial cells. Further, cell line authentication methods should extend beyond genomic profiling to include anatomic, transcriptional, and functional assessments.

Indexed as

AnimalsBiomarkersBlotting, WesternCell LineChoroidEndothelial CellsE-SelectinGene Expression ProfilingGenetic MarkersHumansImmunohistochemistryMacaca mulattaMiceMice, Inbred C57BLMicroscopy, FluorescencePhenotypeBiomarkersE-SelectinGenetic Markers

Identifiers

PMID30508043
PMCPMC6278239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.